Within this context, MEDVi operates as a telehealth serviceaimed at providing physician-supervised GLP-1 weight-loss treatment
Medication concentrations, syringe types, and prescribed doses can vary
External resources New England Journal of Medicine: Tirzepatide Once Weekly for Treatment of Obesity PubMed Central: Efficacy of Tirzepatide vs Semaglutide in Type 2 Diabetes Endocrine Practice: Switching to Tirzepatide From GLP-1 Receptor Agonists In case I do not see you, good afternoon, good evening, and good night
None produce the dramatic results of semaglutide or tirzepatide, but several are considered safe during lactation and can produce meaningful weight loss
Last year removing Zepbound from the formulary forced thousands of patients to consider whether they wanted to stop taking weight loss medicine or switch to Wegovy, an injectable drug that uses a different compound